GGrantIndex
← Leaderboards

Jonathan Lee Slaughter

Research Inst Nationwide Children'S Hosp

$5,056,850
Attributed
$12,095,988
Total exposure
7
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.8M · FY201425
$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$12,095,988 · 7

By mechanism

UH3$4,277,474 · 2
UG3$3,911,192 · 2
R01$3,191,066 · 1
K08$550,744 · 1
R03$165,512 · 1

Most similar at Research Inst Nationwide Children'S Hosp

Same institution · by research overlap

Others in their field

Top investigators on “Pregnancy

Research focus

PregnancyBirthPremature InfantLungLinkInfantChronic Lung DiseasePharmaceutical PreparationsRespiratoryPostnatalInvestigationPatent Ductus ArteriosusLeftFetalMortalitySeverity Of IllnessNeonatalSiteNeurodevelopmentUnited States National Institutes Of HealthInfant HealthProspectiveFuturePulmonary Hypertension

Grant awards (18)

Environmental Influences on Child Health Outcomes (ECHO) and Pregnancy in Ohio$2,298,159
UH3 · FY2025 · OD · contact PI
1/2 percutaneous intervention versus observational trial of arterial ductus in lower gestational age infants (PIVOTAL)$532,533
UH3 · FY2025 · HL
Environmental Influences on Child Health Outcomes (ECHO) and Pregnancy in Ohio$1,773,117
UG3 · FY2024 · OD · contact PI
1/2 percutaneous intervention versus observational trial of arterial ductus in lower gestational age infants (PIVOTAL)$700,785
UH3 · FY2024 · HL
Environmental Influences on Child Health Outcomes (ECHO) and Pregnancy in Ohio$1,325,811
UG3 · FY2023 · OD · contact PI
1/2 percutaneous intervention versus observational trial of arterial ductus in lower gestational age infants (PIVOTAL)$745,997
UH3 · FY2023 · HL
Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes$562,405
R01 · FY2023 · HL · contact PI
1/2 percutaneous intervention versus observational trial of arterial ductus in lower gestational age infants (PIVOTAL)$812,264
UG3 · FY2022 · HL
Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes$560,382
R01 · FY2022 · HL · contact PI
Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes$720,809
R01 · FY2021 · HL · contact PI
Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes$678,150
R01 · FY2020 · HL · contact PI
Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes$669,320
R01 · FY2019 · HL · contact PI
Comparative Effectiveness of Diuretics and Inhaled Corticosteroids for Bronchopulmonary Dysplasia in Preterm Infants.$81,442
R03 · FY2018 · HL · contact PI
Comparative Effectiveness of N-said Treatment Versus No Treatment for PDA in Pret$153,652
K08 · FY2017 · HL · contact PI
Comparative Effectiveness of Diuretics and Inhaled Corticosteroids for Bronchopulmonary Dysplasia in Preterm Infants.$84,070
R03 · FY2017 · HL · contact PI
Comparative Effectiveness of N-said Treatment Versus No Treatment for PDA in Pret$153,652
K08 · FY2016 · HL · contact PI
Comparative Effectiveness of N-said Treatment Versus No Treatment for PDA in Pret$121,780
K08 · FY2015 · HL · contact PI
Comparative Effectiveness of N-said Treatment Versus No Treatment for PDA in Pret$121,660
K08 · FY2014 · HL · contact PI